SBFC Finance vs Concord Biotech: Which IPO should you pick?

August 7, 2023

The issue of SBFC Finance comprises fresh equity issue of Rs 600 crore and an offer for sale (OFS) of Rs 425 crore, while Concord Biotech is completely an OFS of 2.09 crore equity shares up, aggregating up to Rs 1,551 crore.

More To Explore

Sustained deal momentum, discretionary pick up hint at a better FY26 for Infosys

Infosys reported better-than-expected revenue and net profit growth for Q4 2024, increased its FY25 revenue guidance, and plans to hire more freshers. The steady recovery

January 16, 2025

Axis Bank Q3 Results: PAT jumps 4% YoY to Rs 6,304 crore, misses estimates

Axis Bank Q3 Results: The lender reported interest income of Rs 30,954 crore in Q3 FY25, an 11% increase from Rs 27,961 crore in the

January 16, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003